Author:
Senduran N.,Yadav Harlokesh Narayan,Vishwakarma Vishal Kumar,Bhatnagar Priyanka,Gupta Pooja,Bhatia Jagriti,Dinda Amit Kumar
Funder
Institutional Research Grant, AIIMS, New Delhi
Reference22 articles.
1. Update on the treatment of type 2 diabetes mellitus;Marin-Penalver;World J. Diabetes,2016
2. Pharmacological actions of glucagon-like peptide-1, gastric inhibitory polypeptide, and glucagon;Sekar;Int. Rev. Cell Mol. Biol.,2016
3. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallel-group, open-label trial;Pratley;Lancet,2010
4. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomized, 52-week, phase III, double-blind, parallel-treatment trial;Garber;Lancet,2009
5. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice;Tamura;PLoS One,2015
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献